Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations
Recruiting
Observational Study
Healthcare ProvidersPostpartum
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
2,920 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
The objective of our study is to evaluate the impact of vaccine funding for patients seen in outpatient consultations within four healthcare institutions in the Ile-de-France region in France, made possible through the establishment of a tripartite agreement between the hospital group, the Île-de-France Regional Health Agency (ARS IDF), and the Primary Health Insurance Fund (CPAM).
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
For patients:
1. For the assessment of pneumococcal coverage among patients eligible for this vaccination:
* Individuals aged 18 years or older,
* Individuals followed in outpatient consultations within a department and healthcare institution participating in the project…
Inclusion Criteria:
For patients:
1. For the assessment of pneumococcal coverage among patients eligible for this vaccination:
* Individuals aged 18 years or older,
* Individuals followed in outpatient consultations within a department and healthcare institution participating in the project;
* Individuals eligible for pneumococcal vaccination against according to current French recommendations,
* Individuals meeting the eligibility conditions and receiving care under long-term illness coverage (ALD) or benefiting from complementary universal health coverage (C2S) or state medical aid (AME).
2. For the assessment of pertussis vaccination among pregnant women:
* Women aged 18 years or older,
* Women who have had at least one follow-up outpatient consultation from 20 weeks of gestation in a maternity ward participating in the project,
* Women in the immediate postpartum period (during their maternity stay) who have given birth to one or more live children and delivered after 36 weeks of gestation,
* Women who have declared their pregnancy and are covered under maternity insurance (i.e., from the first day of the sixth month of pregnancy until the 12th day after delivery).
For healthcare professionals: all vaccinating healthcare providers working in a participating department or center.
Exclusion Criteria:
* Individuals seen in settings other than outpatient consultations (day hospital, week hospital, conventional hospitalization, International Vaccination Center).
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.